Want to see NGNE full AI Analyst Report?
Neurogene (NGNE) Ownership - Who Owns Neurogene?
Neurogene (NGNE) Ownership Overview
- 7.36% Insiders
- 8.77% Mutual Funds
- 0.19% Other Institutional Investors
- 11.21% ETFs
- 72.47% Public Companies and Individual Investors
The ownership structure of Neurogene (NGNE) stock is a mix of institutional, retail, and individual investors. Approximately 20.17% of the company’s stock is owned by Institutional Investors, 7.36% is owned by Insiders, and 72.47% is owned by Public Companies and Individual Investors.
The ownership structure of Neurogene (NGNE) stock is a mix of institutional, retail, and individual investors. Approximately 20.17% of the company’s stock is owned by Institutional Investors, 7.36% is owned by Insiders, and 72.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 29, 2026 | Rachel Mcminn | $73,979 | |
| Mar 29, 2026 | Christine Mikail Cvijic | $55,304 | |
| Mar 29, 2026 | Julie Jordan | $18,125 | |
| Mar 16, 2026 | Christine Mikail Cvijic | $84,161 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Moore Capital Management Lp | $4,454,452 | |
| Jun 30, 2026 | Driehaus Capital Management Llc | $4,513,956 | |
| Jun 30, 2026 | $33,273,565 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Rachel Mcminn | 1,345,063 | Insider | 6.72% | 37,056,486 |
| Felix Baker | 991,691 | Institution | 4.96% | 27,321,087 |
| Vanguard | 870,113 | Institution | 4.35% | 23,971,613 |
| Ishares | 756,246 | Institution | 3.78% | 20,834,577 |
| Vanguard Index Funds | 524,519 | Institution | 2.62% | 14,450,498 |
| Spdr | 324,817 | Institution | 1.62% | 8,948,708 |
| Franklin Strategic Series | 218,783 | Institution | 1.09% | 6,027,472 |
| Fidelity Advisor Series Vii | 177,200 | Institution | 0.89% | 4,881,860 |
| Steve Weber | 143,528 | Institution | 0.72% | 3,954,196 |
| Louis Moore Bacon | 141,636 | Institution | 0.71% | 3,902,072 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 524,519 | Institution | 2.62% | 14,450,498 |
| Franklin Strategic Series | 218,783 | Institution | 1.09% | 6,027,472 |
| Fidelity Advisor Series Vii | 177,200 | Institution | 0.89% | 4,881,860 |
| Fidelity Salem Street Trust | 141,563 | Institution | 0.71% | 3,900,061 |
| Prudential Sector Funds, Inc. | 126,186 | Institution | 0.63% | 3,476,424 |
| Fidelity Concord Street Trust | 125,603 | Institution | 0.63% | 3,460,363 |
| Vanguard Scottsdale Funds | 76,367 | Institution | 0.38% | 2,103,911 |
| Meridian Fund Inc | 75,859 | Institution | 0.38% | 2,089,915 |
| Fidelity Select Portfolios | 51,100 | Institution | 0.26% | 1,407,805 |
| Schwab Capital Trust | 32,742 | Institution | 0.16% | 902,042 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 520,956 | Institution | 2.60% | 14,492,996 |
| iShares, IWM ETF | 394,294 | Institution | 1.97% | 11,363,553 |
| SPDR, XBI ETF | 279,063 | Institution | 1.39% | 8,042,596 |
| Vanguard, VXF ETF | 174,820 | Institution | 0.87% | 4,863,492 |
| iShares, IWN ETF | 151,264 | Institution | 0.76% | 4,359,428 |
| iShares, IBB ETF | 124,491 | Institution | 0.62% | 3,429,727 |
| Fidelity, FESM ETF | 112,048 | Institution | 0.56% | 3,229,223 |
| Vanguard, VTWO ETF | 91,315 | Institution | 0.46% | 2,540,383 |
| iShares, IWC ETF | 47,638 | Institution | 0.24% | 1,372,927 |
| Vanguard, VHT ETF | 31,569 | Institution | 0.16% | 878,250 |
FAQ
Who Owns Neurogene (NGNE)?
According to the latest TipRanks data, approximately 20.17% of the company's stock is held by institutional investors, 7.36% is held by insiders, and 72.47% is held by public companies and individual investors.
What percentage of Neurogene (NGNE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.17% of Neurogene (NGNE) stock is held by institutional investors: 8.77% by mutual funds, 11.21% by ETFs and 0.19% by other institutional investors.
What percentage of Neurogene (NGNE) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.47% of Neurogene (NGNE) stock is held by public companies and individual investors.
Who owns the most shares of Neurogene (NGNE)?
Rachel Mcminn owns the most shares of Neurogene (NGNE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.